At the news
? NEUTRALIMPACT 3/10 144 filed Apr 15, 2026 at 16:54 ET
Joana Goncalves, an officer of Oruka Therapeutics, filed a Form 144 to notify intent to sell up to 21,000 shares of common stock received from exercised stock options. The sale is part of a pre-arranged 10b5-1 plan and follows prior sales in February and March 2026.
- Joana Goncalves, an officer at Oruka Therapeutics, filed Form 144 for the proposed sale of 21,000 shares.
- The shares were acquired through the exercise of stock options and are being sold under a 10b5-1 plan.
- Prior sales occurred on February 17, 2026 (7,000 shares) and March 16, 2026 (7,641 shares), totaling over 14,000 shares sold or proposed for sale recently.
- The filing date is April 15, 2026, with the underlying options exercised on that date.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access